PROTOCOL SPECIFIC RESEARCH SUPPORT

9.3方案特定研究支持（当地称为方案特定数据管理） 根据国家癌症研究所与癌症中心相关的政策和指南 支持补助金，这一核心小组的研究护士和数据管理人员提供中央管理和 协调、促进和报告癌症临床试验的监督职能 中心最重要的是确定和支持第一阶段和第二阶段的审判， 由癌症中心附属的医生科学家产生的工作。优先提供支助，以确保启动 并完成来自该中心的创新性，可行性或原理证明临床试验 方案和最高优先权的中心。这些包括任何类型的临床转化研究 在用于诊断，预防， 检测或治疗癌症。支持这种研究工作的最终目标是促进 将可行性/第一阶段研究转化为未来的赠款申请或转化为第二和第三阶段研究 由NCI或行业支持。该小组由临床副总监负责监督 Research.

9.3 Protocol-Specific Research Support (locally named Protocol-Specific Data Management) In accordance with the National Cancer Institute Policies and Guidelines Relating to the Cancer Center Support Grant, this core group of research nurses and data managers provides central management and oversight functions for coordinating, facilitating and reporting on the cancer clinical trials of the Cancer Center. Of primary importance is the identification and support of phase I and II trials emanating from the work generated by Cancer Center affiliated physician-scientists. Support is prioritized to ensure the initiation and completion of innovative, feasibility, or proof-of-principle clinical trials originating from the Center's Programs and of highest priority to the Center. These include any kind of clinical translational research culminating in the initial early-phase testing of a candidate agent or device for the diagnosis, prevention, detection, or treatment of cancer. The ultimate goal of supporting such research efforts is to foster the translation of feasibility/phase I studies into future grant applications or into phase II and phase III studies supported by NCI or industry. Oversight of this group is provided by the Associate Director of Clinical Research.